Chartwell Investment Partners’s Ingevity NGVT Stock Holding History

Chartwell Investment Partners’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-15,355	Closed	-$1.34M	–	413
2019 Q4	$1.34M	Sell	15,355 -12,944	-46%	-$1.13M	0.04%	333
2019 Q3	$2.4M	Sell	28,299 -25,479	-47%	-$2.27M	0.08%	290
2019 Q2	$5.66M	Buy	53,778 +2,511	+5%	+$252K	0.18%	188
2019 Q1	$5.41M	Buy	51,267 +648	+1%	+$65.1K	0.18%	201
2018 Q4	$4.24M	Sell	50,619 -20,777	-29%	-$1.88M	0.15%	206
2018 Q3	$7.27M	Buy	71,396 +35,004	+96%	+$3.38M	0.21%	163
2018 Q2	$2.94M	Buy	36,392 +19,196	+112%	+$1.53M	0.09%	306
2018 Q1	$1.27M	Buy	+17,196	New	+$1.29M	0.04%	355

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Ardevora Asset Management London, United Kingdom $1.12B AUM 26.09% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

Chartwell Investment Partners's NGVT Position: Q1 2020 in Review

Chartwell Investment Partners sold out of Ingevity (NGVT) in Q1 2020, closing a stake of 15,355 shares — an estimated $1.34M sold.

Chartwell Investment Partners first reported a position in NGVT in Q1 2018 and held it in 8 quarters. The position peaked at $7.27M in Q3 2018. 272 funds tracked by Wall St. Rank hold NGVT as of Q1 2020.

Chartwell Investment Partners reported no remaining Ingevity position as of Q1 2020 after selling out during the quarter.
Chartwell Investment Partners sold 15,355 Ingevity shares in Q1 2020, an estimated $1.34M.
Chartwell Investment Partners first reported a position in Ingevity in Q1 2018 and held it in 8 quarters.
Chartwell Investment Partners's Ingevity position peaked at $7.27M in Q3 2018.
272 funds tracked by Wall St. Rank held Ingevity as of Q1 2020.

Based on Chartwell Investment Partners's 13F filing for Q1 2020, filed 30 Apr 2020.